Overview

FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer

Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
the aim of this study is to observe the effect of irinotecan-based regimen in patients with advanced colorectal cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborator:
First Affiliated Hospital, Sun Yat-Sen University
Treatments:
Irinotecan
Oxaliplatin